USANA Health Sciences Inc. disclosed that Timothy E. Wood, a director of the company, acquired 1,632 shares of common stock and 1,632 restricted stock units on July 23, 2026. The transaction, reported through an SEC Form 4 filing, demonstrates insider confidence in the nutritional products company. Wood's total beneficial ownership of common stock increased to 12,245 shares following the acquisition.

Key Points

  • NYSE: USNA
  • Director Timothy E. Wood acquired 1,632 shares of common stock on July 23, 2026
  • Wood also received 1,632 restricted stock units vesting in four equal tranches from July 2026 through April 2027
  • Wood's direct common stock ownership rose to 12,245 shares; restricted stock unit ownership totaled 4,895 units following the transaction
  • The filing was made on July 27, 2026, four days after the transaction date

Director's Common Stock Purchase Details

Timothy E. Wood, listed as a director of USANA Health Sciences Inc., executed a purchase of 1,632 shares of common stock on July 23, 2026. The transaction code in the filing indicates this was a regular purchase transaction. Following this acquisition, Wood's direct beneficial ownership of common stock increased to 12,245 shares. The filing does not disclose the purchase price for this common stock transaction.

The acquisition represents a direct ownership position, meaning Wood holds the shares in his own name rather than through any indirect ownership structure or entity. This direct ownership stake underscores Wood's personal investment in the company's performance and strategic direction. The filing establishes Wood's beneficial ownership position as of the transaction date and provides transparency regarding insider trading activity.

Restricted Stock Unit Grant and Vesting Schedule

In addition to the common stock purchase, Wood received a grant of 1,632 restricted stock units on the same transaction date. Restricted stock units represent contingent rights to receive shares of USANA common stock upon satisfaction of specified conditions. Each unit ultimately converts into one share of common stock. Following the grant, Wood's total beneficial ownership of restricted stock units reached 4,895 units.

The restricted stock units are subject to a four-tranche vesting schedule spanning nine months. The filing specifies that 25 percent of the granted units will vest on each of the following dates: July 23, 2026, October 22, 2026, January 21, 2027, and April 22, 2027. This graduated vesting structure aligns Wood's interests with the company's longer-term performance and retains a portion of compensation as contingent upon continued service and value creation through the following fiscal periods.

Regulatory Filing and Disclosure Timeline

The Form 4 filing was executed on July 27, 2026, three business days after the transaction occurred on July 23, 2026. Joshua Foukas, identified as an attorney-in-fact, signed the document on behalf of Wood. The filing complies with Section 16(a) of the Securities Exchange Act of 1934, which requires officers, directors, and beneficial owners of more than ten percent of a company's equity to report changes in ownership.

The timely filing of insider transaction disclosures serves investors by providing prompt notification of trading activity by company insiders. This transparency requirement allows market participants to assess insider sentiment and potential signals regarding the company's valuation and prospects. Wood's position as a director makes his trading activity particularly noteworthy to investors monitoring insider investment patterns.

Wood's Role and Beneficial Ownership Status

Timothy E. Wood holds the position of director at USANA Health Sciences Inc., as indicated by the checked box in the "Relationship of Reporting Person(s) to Issuer" section of the Form 4. The filing does not identify Wood as holding an officer title or as a beneficial owner of more than ten percent of the company's outstanding shares. His director status triggers reporting obligations under securities regulations whenever he engages in transactions affecting his beneficial ownership of the company's securities.

Directors occupy a position of trust and fiduciary responsibility within a company's governance structure. Their investment decisions and trading patterns often reflect their assessment of company prospects and management execution. Investors frequently monitor director-level transactions as potential indicators of insider confidence or concern regarding company valuation and strategic direction. Wood's acquisition of both common shares and restricted stock units on the same date may indicate coordinated compensation or investment activity.

Common Stock Disposition During Reporting Period

The filing also discloses that Wood disposed of 408 shares of common stock on July 23, 2026, the same date as his other transactions. The disposition was coded as "F" in the transaction code column, and the shares were sold at $20.92 per share. This sale offset a portion of Wood's common stock acquisition, resulting in a net increase of 1,224 shares in his direct beneficial ownership position during the reporting period.

The combined effect of Wood's purchase of 1,632 shares and sale of 408 shares demonstrates a net increase in common stock exposure. The $20.92 sale price provides a marker for USANA's trading price on the transaction date. Investors evaluating insider trading patterns may note that the sale of fewer shares than purchased could signal an overall positive outlook on the company's prospects, though the filing provides no narrative explanation for the disposition.

Beneficial Ownership Calculation and Changes

Following completion of all transactions reported in the July 23, 2026 activity, Wood's beneficial ownership position consisted of 12,245 shares of common stock held directly and 4,895 restricted stock units also held directly. The calculation reflects the net effect of acquisitions and dispositions executed on that single date. These ownership figures establish the baseline for future Form 4 filings should Wood engage in additional securities transactions.

The restricted stock units, while representing a contingent claim on USANA shares rather than actual shares, are counted in beneficial ownership calculations because they provide Wood with the economic equivalent of share ownership upon vesting. The four-tranche vesting schedule means that Wood's actual shareholding will increase progressively as each vesting date passes, provided he remains employed or engaged with the company through those dates. The filing creates a clear record of Wood's equity stake and future ownership expectations.

Insider Trading Transparency and Market Implications

Form 4 filings represent a core component of the SEC's insider trading disclosure regime, designed to promote market integrity and investor confidence. The publication of Wood's transaction details within four business days of execution reflects regulatory priorities in ensuring timely, accurate information reaches market participants. Investors and analysts use these filings to track insider sentiment, identify potential trading patterns, and evaluate the alignment of insider interests with shareholder interests.

The acquisition of restricted stock units as part of director compensation is a standard practice among public companies seeking to retain leadership talent and align management incentives with shareholder value creation. The multi-month vesting period encourages continued engagement and performance over an extended timeframe. Investors may interpret Wood's simultaneous purchase of common stock as an additional signal of confidence beyond his compensation-based equity grants.

USANA Health Sciences and Director Governance

USANA Health Sciences Inc. operates as a direct selling company specializing in nutritional products and personal care items. The company maintains governance structures including a board of directors overseeing management and strategic direction. Director participation in equity ownership, as demonstrated by Wood's transactions, represents one mechanism through which boards align leadership interests with shareholder outcomes and company performance.

The filing identifies USANA's trading ticker as USNA on the NYSE, indicating the company's status as a publicly listed enterprise subject to comprehensive SEC reporting requirements. Directors of NYSE-listed companies face heightened regulatory obligations regarding disclosure of securities transactions, providing market participants with detailed information about insider trading patterns. Wood's filing exemplifies these transparency requirements in action.

Tax and Regulatory Considerations for Restricted Stock Units

Restricted stock units receive specific treatment under securities laws and tax regulations distinct from outright share ownership. Until vesting occurs, unit holders do not possess voting rights or dividend rights associated with the underlying common stock. The Form 4 filing indicates that Wood's units vest according to the specified schedule, after which each unit will convert to one share conferring full shareholder rights. The filing notes that each unit represents a contingent right to receive one share, establishing the economic relationship between units and shares.

The four-tranche vesting schedule may align with USANA's fiscal calendar or performance periods. The company did not disclose in this filing whether vesting is contingent upon achievement of performance objectives, continued employment, or solely upon the passage of time. The vesting dates spanning from July 2026 through April 2027 suggest a nine-month retention or commitment period. Investors should consult additional company disclosures, such as proxy statements or equity award documents, for complete details regarding any performance conditions or other vesting criteria.